Haemonetics Corporation HAE
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | -38.22% | -41.05% | -41.97% | 34.88% | 35.84% |
| Total Depreciation and Amortization | -3.79% | -4.18% | -3.00% | -0.48% | 6.56% |
| Total Amortization of Deferred Charges | -8.96% | -8.96% | -8.96% | -22.09% | -22.09% |
| Total Other Non-Cash Items | 240.45% | 315.58% | 25,456.64% | 116.59% | 154.52% |
| Change in Net Operating Assets | 195.22% | 115.07% | 76.80% | 117.14% | 84.45% |
| Cash from Operations | 19.34% | 44.85% | 61.35% | 162.16% | 240.27% |
| Capital Expenditure | -41.65% | 1.19% | 16.54% | -1.46% | 9.50% |
| Sale of Property, Plant, and Equipment | -43.22% | -58.75% | -94.09% | -84.55% | -85.45% |
| Cash Acquisitions | -- | -3,329.06% | 60.12% | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | 2,786.07% | 2,786.07% |
| Other Investing Activities | 24.58% | -15.76% | -129.94% | -162.07% | -109.95% |
| Cash from Investing | -158.92% | -203.03% | -10.90% | 61.19% | 85.87% |
| Total Debt Issued | -- | -- | -68.42% | -100.00% | -100.00% |
| Total Debt Repaid | -6,400.00% | -7,499.19% | 39.08% | 98.89% | 98.90% |
| Issuance of Common Stock | 22.28% | -4.64% | -5.28% | -4.68% | 0.05% |
| Repurchase of Common Stock | 54.79% | 22.39% | 23.48% | -169.76% | -171.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6,933.07% | 64.13% | 99.91% | 99.90% | 99.77% |
| Cash from Financing | 4.57% | -0.10% | -264.00% | -216.08% | -175.15% |
| Foreign Exchange rate Adjustments | 1,806.06% | -127.03% | 605.55% | 213.53% | -101.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,150.05% | -34.90% | -147.92% | -66.48% | 94.48% |